Inventor

MOUSSY ALAIN

FR27 patents

⚠️ This page may combine multiple inventors who share the name “MOUSSY ALAIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MOUSSY ALAIN

AB SCIENCE

2-aminoaryloxazole compounds as tyrosine kinase inhibitors

2-(3-Aminoaryl)amino-4-aryl-thiazoles for the treatment of diseases

Use of masitinib for treatment of an amyotrophic lateral sclerosis patient subpopulation

2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors

Potent, selective and non toxic c-kit inhibitors

Masitinib for the treatment of sickle cell disease

Use of tyrosine kinase inhibitors for treating inflammatory diseases

Use of tyrosine kinase inhibitors for treating allergic diseases

Use of tyrosine kinase inhibitors for treating inflammatory bowel diseases (IBD)

Aminothiazole compounds as kinase inhibitors and methods of using the same

Use of masitinib for treatment of cancer in patient subpopulations identified using predictor factors

Treatment of mastocytosis with masitinib

Compounds with anti-tumoral activity

Oxazole derivatives that inhibit Syk

Benzimidazole derivatives as selective proteine kinase inhibitors

Diazaspiroalkaneone-substituted oxazole derivatives as spleen tyrosine kinase inhibitors

MOUSSY ALAIN

Treatment of severe persistant asthma with masitinib

Aminothiazole compounds as kinase inhibitors and methods of using the same

Treatment of multiple sclerosis with masitinib

Combination treatment of solid cancers with antimetabolites and tyrosine kinase inhibitors

2-aminoaryloxazole compounds as tyrosine kinase inhibitors

Process for the synthesis of 2-aminothiazole compounds as kinase inhibitors

Thiazole and oxazole kinase inhibitors

CIUFOLINI MARCO

2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors

2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors

GRIERSON DAVID

Substituted oxazole derivatives and their use as tyrosine kinase inhibitors

BENJAHAD ABDELLAH

Selective protein kinase inhibitors